HIKAL

Hikal Share Price

₹399.45 -5.6 (-1.38%)

29 Mar, 2025 04:09

SIP TrendupStart SIP in HIKAL

Start SIP

Performance

  • Low
  • ₹395
  • High
  • ₹409
  • 52 Week Low
  • ₹262
  • 52 Week High
  • ₹465
  • Open Price₹405
  • Previous Close₹405
  • Volume105,254

Investment Returns

  • Over 1 Month + 16%
  • Over 3 Month + 4.72%
  • Over 6 Month + 7.45%
  • Over 1 Year + 50.08%
SIP Lightning

Smart Investing Starts Here Start SIP with Hikal for Steady Growth!

Invest Now

Hikal Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 66
  • PEG Ratio
  • 16.1
  • Market Cap Cr
  • 4,925
  • P/B Ratio
  • 4.1
  • Average True Range
  • 15.16
  • EPS
  • 6.04
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 11.38
  • RSI
  • 56.94
  • MFI
  • 66.64

Hikal Financials

Hikal Technicals

EMA & SMA

Current Price
₹399.45
-5.6 (-1.38%)
pointer
  • stock-down_img
  • Bearish Moving Average 4
  • stock-up_img
  • Bullish Moving Average 12
  • 20 Day
  • ₹390.44
  • 50 Day
  • ₹378.48
  • 100 Day
  • ₹373.45
  • 200 Day
  • ₹360.97

Resistance and Support

401.05 Pivot Speed
  • R3 422.00
  • R2 415.55
  • R1 407.50
  • S1 393.00
  • S2 386.55
  • S3 378.50

What's your outlook on Hikal?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Hikal Ltd. is a leading Indian company providing pharmaceutical and crop protection solutions, including Active Pharmaceutical Ingredients (APIs), intermediates, and specialty chemicals. It serves global markets, supplying high-quality products to pharmaceutical, agrochemical, and animal health industries.

Hikal has an operating revenue of Rs. 1,821.50 Cr. on a trailing 12-month basis. An annual revenue de-growth of -12% needs improvement, Pre-tax margin of 5% is okay, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 36%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 11% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 12% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 86 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 55 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Hikal Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-04 Quarterly Results & Interim Dividend
2024-11-12 Quarterly Results
2024-08-01 Quarterly Results
2024-05-09 Audited Results & Final Dividend
2024-02-08 Quarterly Results & Interim Dividend
Date Purpose Remarks
2025-02-08 INTERIM Rs.0.60 per share(30%)Interim Dividend
2024-09-04 FINAL Rs.0.60 per share(30%)Final Dividend (BC dates changed as RD and XD also revised)
2024-02-20 INTERIM Rs.0.60 per share(30%)Interim Dividend
2023-02-14 INTERIM Rs.0.60 per share(30%)Interim Dividend
2022-09-15 FINAL Rs.0.40 per share(20%)Final Dividend
View More

Hikal F&O

Hikal Shareholding Pattern

68.85%
2.92%
0%
6.06%
16.65%
5.52%

About Hikal

  • NSE Symbol
  • HIKAL
  • BSE Symbol
  • 524735
  • Managing Director
  • Mr. Sameer Hiremath
  • ISIN
  • INE475B01022

Similar Stocks to Hikal

Hikal FAQs

Hikal share price is ₹399 As on 29 March, 2025 | 03:55

The Market Cap of Hikal is ₹4925.3 Cr As on 29 March, 2025 | 03:55

The P/E ratio of Hikal is 66 As on 29 March, 2025 | 03:55

The PB ratio of Hikal is 4.1 As on 29 March, 2025 | 03:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23